Thrombocytopenia due to intravenous immunglobulin therapy in a patient with Guillain Barre syndrome: Case report

dc.contributor.authorKutlucan, Ali
dc.contributor.authorErdoğan, Murat
dc.contributor.authorDikici, Süber
dc.contributor.authorAydın, Yusuf
dc.contributor.authorCoşkun, H.
dc.contributor.authorCelbek, G.
dc.contributor.authorErcan, Nurten
dc.date.accessioned2020-04-30T13:33:54Z
dc.date.available2020-04-30T13:33:54Z
dc.date.issued2013
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractThrombocytopenia is a common disease and diagnosis is based on the findings in a variety of reasons. One of the major and reversible cause of thrombocytopenia is drug-induced thrombocytopenia. We herein report a Guillain-Barre case developed thrombocytopenia after intravenous immunoglobulin (IVIG) administration. A 36-year-old female patient, who diagnosed as Guillain Barre and had an idiopathic thrombocytopenic purpura attack 18 month ago, treated 5 day course of 30 g/day dose of IVIG. Initial thrombocyte level of the patient was 193×103/?L, but its level was observed on further days after IVIG administration as 62.8×103/?L and 5.74×103/?L, respectively. Platelet counts did not respond to the pulse methylprednisolone so cyclosporine therapy was applied. Patient's platelet counts became to normal ranges after cyclosporine treatment. Copyright © 2013 by Türkiye Klinikleri.en_US
dc.identifier.endpage77en_US
dc.identifier.issn1306-7656
dc.identifier.issue2en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage75en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12684/759
dc.identifier.volume25en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofTurkiye Klinikleri Cardiovascular Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGuillain-Barre syndrome; Immunoglobulins; Intravenous; Thrombocytopeniaen_US
dc.titleThrombocytopenia due to intravenous immunglobulin therapy in a patient with Guillain Barre syndrome: Case reporten_US
dc.title.alternativeGuillain-Barre sendromlu hastada i?ntravenöz i?mmü nglobulin tedavisi sonrasi gelişen trombositopenien_US
dc.typeArticleen_US

Dosyalar